Schizophrenia Trial, Recruiting NCT07701343 Sponsor: Central South University Condition: Schizophrenia
Back to Schizophrenia

Schizophrenia Trial, Recruiting

NCT07701343
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 to 50 years who have been diagnosed with schizophrenia, confirmed using a standard structured interview process.
  • People who score below a certain threshold on a specific memory and thinking test called the MATRICS Consensus Cognitive Battery (MCCB), particularly in an area related to spatial memory.
  • People who are currently taking one or two antipsychotic medications at a stable dose for at least one week before joining, with no use of mood stabilizers, antidepressants, or high doses of sedative medications (such as benzodiazepines above a certain level), and whose medication type and dose would remain unchanged during the trial.
  • People who have some difficulty carrying out everyday activities due to their condition.
  • People who are willing to take part and able to sign a written consent form.

Who may not be able to join:

  • People who have been diagnosed with any other mental health condition in addition to schizophrenia, as defined by standard diagnostic guidelines.
  • People who have significant mood symptoms or a substance use disorder (not including caffeine or tobacco use).
  • People who have any medical reason that would make a brain stimulation technique called transcranial alternating current stimulation (tACS) unsafe for them (confirm with trial site for specifics).
  • People who have received any other type of electrical or magnetic brain stimulation treatment within the month before joining.
  • People who have a history of, or currently have, a major physical illness, a neurological condition, or a brain injury that may affect how the brain works or is structured.
  • Women who are pregnant, breastfeeding, or planning to become pregnant during the study period.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 15874179855

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Central South University
Registry
ClinicalTrials.gov
Start date
6 July 2026
Est. completion
31 October 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Working Memory Accuracy; Working Memory Reaction Time

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov